[. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
作者信息
Vischer W A
出版信息
Schweiz Med Wochenschr. 1967 Mar 11;97(10):308.
PMID:5585384
Abstract
摘要
相似文献
1
[. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Schweiz Med Wochenschr. 1967 Mar 11;97(10):308.
2
Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):25-33.
3
Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
Dermatol Int. 1969 Jan-Mar;8(1):21-7. doi: 10.1111/j.1365-4362.1969.tb05324.x.
4
Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Lepr Rev. 1971 Sep;42(3):178-87. doi: 10.5935/0305-7518.19710021.
5
The treatment of erythema nodosum leprosum with B.663. A controlled study.
Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):11-6.
6
Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Int J Lepr Other Mycobact Dis. 1971 Jul-Sep;39(3):738-41.
7
Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
Int J Lepr Other Mycobact Dis. 1968 Apr-Jun;36(2):171-8.
8
Drugs for leprosy.
Trop Doct. 1973 Apr;3(2):92-5. doi: 10.1177/004947557300300214.
9
Clofazimine in leprosy.
Br Med J. 1972 Feb 19;1(5798):506-7. doi: 10.1136/bmj.1.5798.506-d.
10
Clofazimine (B663, Geigy) in leprosy reactions.
Australas J Dermatol. 1972 Apr;13(1):31-5. doi: 10.1111/j.1440-0960.1972.tb00480.x.
Zotero 插件